Erythromycin News and Research

RSS
Erythromycin is a macrolide antibiotic that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people who have an allergy to penicillins. For respiratory tract infections, it has better coverage of atypical organisms, including mycoplasma and Legionellosis. Erythromycin is an antibiotic produced from a strain of Streptomyces erythraeus.
Antibiotics with blood pressure medications may cause hypotension

Antibiotics with blood pressure medications may cause hypotension

Breast cancer patients taking tamoxifen anxious to have CYP2D6 genetic test

Breast cancer patients taking tamoxifen anxious to have CYP2D6 genetic test

E. coli host bacterium produces antibiotic erythromycin A

E. coli host bacterium produces antibiotic erythromycin A

VYTORIN reduces major vascular events in patients with chronic kidney disease

VYTORIN reduces major vascular events in patients with chronic kidney disease

Inspire third quarter net loss decreases to $7.6 million

Inspire third quarter net loss decreases to $7.6 million

Fera Pharmaceuticals launches Garamycin Ophthalmic Ointment

Fera Pharmaceuticals launches Garamycin Ophthalmic Ointment

Bristol-Myers, Otsuka launch My SPRYCEL Support program to assist patients with CML

Bristol-Myers, Otsuka launch My SPRYCEL Support program to assist patients with CML

FDA approves Akorn's Erythromycin Ophthalmic Ointment USP 1 g

FDA approves Akorn's Erythromycin Ophthalmic Ointment USP 1 g

Quick-Med receives patent for MultiStat technology to treat Rosacea

Quick-Med receives patent for MultiStat technology to treat Rosacea

Scientists suggest combination vaccine prevents pertussis

Scientists suggest combination vaccine prevents pertussis

Akorn second-quarter consolidated revenue increases 24% to $20.2 million

Akorn second-quarter consolidated revenue increases 24% to $20.2 million

Quick-Med Technologies receives Notice of Allowance for MultiStat family of compounds

Quick-Med Technologies receives Notice of Allowance for MultiStat family of compounds

Advanced Life Sciences expands partnership with U.S. Government to assess Restanza against STI's

Advanced Life Sciences expands partnership with U.S. Government to assess Restanza against STI's

Inspire Pharmaceuticals reports net loss of $14.8M for first-quarter 2010

Inspire Pharmaceuticals reports net loss of $14.8M for first-quarter 2010

FDA approves Akorn's ANDA supplement for Erythromycin

FDA approves Akorn's ANDA supplement for Erythromycin

Cempra to make poster presentations on CEM-101 and CEM-102 at ECCMID 2010

Cempra to make poster presentations on CEM-101 and CEM-102 at ECCMID 2010

Inspire Pharmaceuticals reports net loss of $2.6 million for 2009 fourth quarter

Inspire Pharmaceuticals reports net loss of $2.6 million for 2009 fourth quarter

Novartis' Tasigna capsules granted priority review by FDA for treatment of adult patients with Ph+ CML

Novartis' Tasigna capsules granted priority review by FDA for treatment of adult patients with Ph+ CML

Antibiotics program of Giant Eagle results in more than $3M in free prescriptions for customers

Antibiotics program of Giant Eagle results in more than $3M in free prescriptions for customers

Eli Lilly and Kowa Pharmaceuticals America to co-promote LIVALO in the U.S

Eli Lilly and Kowa Pharmaceuticals America to co-promote LIVALO in the U.S